(lp0
S"Horizon Fights Par Pharma's Generic Of Urine Disorder Drug Law360  - Jul 1, 2016 Horizon Therapeutics Inc. claims Par Pharmaceutical Inc. infringed its three Ravicti patents when it applied for an abbreviated new drug application with the Food and Drug Administration."
p1
aS"Buzz Stocks: Sears Holdings Corp, Horizon Pharma PLC, and Voyager Therapeutics Inc Schaeffers Research  - Dec 8, 2016 U.S. stock futures are trading above fair value, following the European Central Bank's  latest policy decision. Among specific equities in focus today are retail stock Sears Holdings Corp , as well as drugmakers Horizon Pharma PLC&nbsp;...Here's Our Take On Horizon Pharma PLC 's Fall Out And Regeneron ... - Market ExclusiveHorizon Pharma  Announces ACTIMMUNE Phase 3 in FA Missed Primary Endpoint - StreetInsider.com"
p2
aS'Analyst Recommendations And Earnings Forecast: Horizon Global Corporation (HZN ... Post Analyst - Mar 17, 2017 Horizon Global Corporation  has made its way to a 12-month gain of 21.92%. Turning to INSYS Therapeutics, Inc. , its shares were trading at $10.06 a retreat of $-0.49, on the trading floor. The stock, after opening at $10.46, touched ...'
p3
aS"PTAB Upholds Patent For Horizon's Urine Disorder Drug Law360  - Nov 4, 2016 Horizon picked up Ravicti and a second drug used to treat urea cycle disorders, Buphenyl, when it acquired California biotech company Hyperion Therapeutics Inc. for $1.1 billion last year. The disorders are caused by genetic mutations that prevent a&nbsp;..."
p4
aS'Stemline Therapeutics  Reaches $8.70 After 5.00% Up Move, Kingdon ... Herald KS - Mar 22, 2017 Horizon Pharma PLC  has declined 37.30% since August 15, 2016 and is downtrending. It has underperformed by 44.33% the S&amp;P500.'
p5
aS'BUZZ-US STOCKS ON THE MOVE-Intel, Horizon, Gordmans, Sunworks Nasdaq - Mar 13, 2017 [nL3N1GQ3OY] ** OSIRIS THERAPEUTICS INC &lt;OSIR.O&gt;, $4.25, -18.27 pct The regenerative medicine developer said on Friday it received a letter from the Nasdaq notifying that its stock will be suspended from trading on March 14.US STOCKS ON THE MOVE-Intel, Kronos, Aethlon, Aralez, Ciber - Times of India'
p6
aS'vTv Therapeutics Inc.  Files An 8-K Unregistered Sales of Equity ... Market Exclusive - Mar 27, 2017 On March 24, 2017, vTv Therapeutics Inc.  borrowed $7.5 million representing the second tranche under its Venture Loan and Security Agreement , dated October 28, 2016, with Horizon Technology Finance&nbsp;...'
p7
aS'Hedge Fund Sees 21% Returns on Advice From Nobel Prize Pickers Bloomberg - Mar 27, 2017 Thanks to the advice from a range of professors, Swedish hedge fund Rhenman Healthcare Equity L/S has delivered an average annual return of 21 percent since it started in 2009.'
p8
aS'Wall Street Cheers These Two Rising Stocks: Esperion Therapeutics Inc (ESPR ... Smarter Analyst - Mar 20, 2017 Esperion Therapeutics Inc  and Nektar Therapeutics  are skyrocketing with a fury today on back of major clinical strides forward that have investors today eagerly watching these needle-movers ascend up through the stratosphere ...'
p9
aS"Pain Therapeutics' Remoxy ER Secures FDA Regulatory Guidance  Investopedia - Mar 21, 2017 The update followed a meeting between Pain Therapeutics and the FDA held on February 13, 2017, during which an agreement was reached on the requirements for additional assessment for Remoxy's approval."
p10
a.